1. Brown P, Pratt AG, Hyrich KL. Therapeutic advances in rheumatoid arthritis. BMJ 2024;384:e070856.

2. Di Matteo A, Bathon JM, Emery P. Rheumatoid arthritis. Lancet 2023;402:2019–2033.

3. GBD 2021 Rheumatoid Arthritis Collaborators. Global, regional, and national burden of rheumatoid arthritis, 1990–2020, and projections to 2050: a systematic analysis of the Global Burden of Disease Study 2021. Lancet Rheumatol 2023;5:e594–e610.

4. Wu D, Luo Y, Li T, et al. Systemic complications of rheumatoid arthritis: focus on pathogenesis and treatment. Front Immunol 2022;13:1051082.

5. Abdelhafiz D, Baker T, Glascow DA, Abdelhafiz A. Biomarkers for the diagnosis and treatment of rheumatoid arthritis - a systematic review. Postgrad Med 2023;135:214–223.

6. Jang S, Kwon EJ, Lee JJ. Rheumatoid arthritis: pathogenic roles of diverse immune cells. Int J Mol Sci 2022;23:905.

7. Tofigh R, Hosseinpourfeizi M, Baradaran B, Teimourian S, Safaralizadeh R. Rheumatoid arthritis and non-coding RNAs; how to trigger inflammation. Life Sci 2023;315:121367.

8. Nemeth K, Bayraktar R, Ferracin M, Calin GA. Non-coding RNAs in disease: from mechanisms to therapeutics. Nat Rev Genet 2024;25:211–232.

9. Chen R, Zhou D, Chen Y, Chen M, Shuai Z. Understanding the role of exosomal lncRNAs in rheumatic diseases: a review. PeerJ 2023;11:e16434.

10. Miao C, Bai L, Yang Y, Huang J. Dysregulation of lncRNAs in rheumatoid arthritis: biomarkers, pathogenesis and potential therapeutic targets. Front Pharmacol 2021;12:652751.

11. Lao MX, Xu HS. Involvement of long non-coding RNAs in the pathogenesis of rheumatoid arthritis. Chin Med J (Engl) 2020;133:941–950.

12. Sun S, Liang L, Tian R, et al. LncRNA expression profiling in exosomes derived from synovial fluid of patients with rheumatoid arthritis. Int Immunopharmacol 2024;130:111735.

13. Elamir AM, Senara S, Abdelghaffar NK, Gaber SN, El Sayed HS. Diagnostic role of lncRNA GAS5 and its genetic polymorphisms rs2067079, rs6790 and rs17359906 in rheumatoid arthritis. Biomed Rep 2021;15:93.

14. Erfan R, Shaker OG, Khalil MAF, et al. Long non-coding RNA PVT1 and its target miRNA-146a as potential prognostic biomarkers in rheumatoid arthritis patients. Life (Basel) 2021;11:1382.

15. Fu Q, Song MJ, Fang J. LncRNA OSER1-AS1 regulates the inflammation and apoptosis of rheumatoid arthritis fibroblast like synoviocytes via regulating miR-1298-5p/E2F1 axis. Bioengineered 2022;13:4951–4963.

16. Peng H, Ren S, Liu Y, et al. Elevated expression of the long noncoding RNA IFNG-AS1 in the peripheral blood from patients with rheumatoid arthritis. J Immunol Res 2020;2020:6401978.

17. Shaker OG, Mahmoud RH, Abdelaleem OO, et al. Expression profile of long noncoding RNAs, lnc-Cox2, and HOTAIR in rheumatoid arthritis patients. J Interferon Cytokine Res 2019;39:174–180.

18. Shuai ZQ, Wang ZX, Ren JL, Yang XK, Xu B. Differential expressions and potential clinical values of lncRNAs in the plasma exosomes of rheumatoid arthritis. Int Immunopharmacol 2024;128:111511.

19. Sun L, Tu J, Liu C, Pan A, Xia X, Chen X. Analysis of lncRNA expression profiles by sequencing reveals that lnc-AL928768.3 and lnc-AC091493.1 are novel biomarkers for disease risk and activity of rheumatoid arthritis. Inflammopharmacology 2020;28:437–450.

20. Tofigh R, Hosseinpourfeizi M, Safaralizadeh R, Ghoddusifar S, Baradaran B. Serum levels of long non-coding RNAs NEAT1, GAS5, and GAPLINC altered in rheumatoid arthritis. Curr Rheumatol Rev 2024;20:182–190.

21. Wahba AS, Ibrahim ME, Mesbah NM, Saleh SM, Abo-Elmatty DM, Mehanna ET. Serum LINC00305 expression and its genetic variant rs2850711 are associated with clinical and laboratory features of rheumatoid arthritis. Br J Biomed Sci 2020;77:142–147.

22. Wang Z, Zhang W, Li S, et al. Multiple time-point assessment of lncRNA MEG3 shows potential to monitor treatment efficacy in rheumatoid arthritis patients. Biomark Med 2021;15:1261–1270.

23. Wen J, Liu J, Jiang H, et al. lncRNA expression profiles related to apoptosis and autophagy in peripheral blood mononuclear cells of patients with rheumatoid arthritis. FEBS Open Bio 2020;10:1642–1654.

24. Zhao X, Lin W, Zhou W. Clinical significance of long non-coding RNA NORAD in rheumatoid arthritis. Adv Rheumatol 2024;64:9.

25. Xie B, Lin F, Bao W, et al. Long noncoding RNA00324 is involved in the inflammation of rheumatoid arthritis by targeting miR-10a-5p via the NF-κB pathway. Immun Inflamm Dis 2023;11:e906.

26. Kiełbowski K, Ćmil M, Biniek WJ, Bakinowska E, Pawlik A. The role of long non-coding RNA in rheumatoid arthritis. Int J Mol Sci 2025;26:560.

27. Mo XB, Sun YH, Wu LF, et al. A novel long non-coding RNA, lnc-RNU12, influences the T-cell cycle via c-JUN and CCNL2 in rheumatoid arthritis. Rheumatology (Oxford) 2023;62:1955–1963.

28. Shui X, Chen S, Lin J, Kong J, Zhou C, Wu J. Knockdown of lncRNA NEAT1 inhibits Th17/CD4+ T cell differentiation through reducing the STAT3 protein level. J Cell Physiol 2019;234:22477–22484.

29. Xiang M, Sun Z, Ge Y, et al. Long non-coding RNA lncTAF15:1-1 promotes CCL5 secretion and cell migration of monocyte-derived dendritic cells via PI3K/AKT/mTOR pathway in systemic lupus erythematosus. J Inflamm Res 2025;18:10389–10402.

30. Ye L, Shi H, Yu C, et al. LncRNA Neat1 positively regulates MAPK signaling and is involved in the pathogenesis of Sjögren’s syndrome. Int Immunopharmacol 2020;88:106992.

31. Zhu X, Zhu Y, Ding C, et al. LncRNA H19 regulates macrophage polarization and promotes Freund’s complete adjuvant-induced arthritis by upregulating KDM6A. Int Immunopharmacol 2021;93:107402.

32. Mo BY, Guo XH, Yang MR, et al. Long non-coding RNA GAPLINC promotes tumor-like biologic behaviors of fibroblast-like synoviocytes as MicroRNA sponging in rheumatoid arthritis patients. Front Immunol 2018;9:702.

33. Sun L, Hu L, Chen P, Li Y, Tu J, Chen J. Long non-coding RNA AL928768.3 promotes rheumatoid arthritis fibroblast-like synoviocytes proliferation, invasion and inflammation, while inhibits apoptosis via activating lymphotoxin beta mediated NF-κB signaling pathway. Inflammation 2024;47:543–556.

34. Yang J, Li Y, Wang L, Zhang Z, Li Z, Jia Q. LncRNA H19 aggravates TNF-α-induced inflammatory injury via TAK1 pathway in MH7A cells. Biofactors 2020;46:813–820.

35. Zhuo Q, Wei L, Yin X, et al. LncRNA ZNF667-AS1 alleviates rheumatoid arthritis by sponging miR-523-3p and inactivating the JAK/STAT signalling pathway. Autoimmunity 2021;54:406–414.

36. Liu YR, Wang JQ, Zhou TS, Fang L, Li J, Xia Q. LncRNA-MEG3/miR-93-5p/SMAD7 axis mediates proliferative and inflammatory phenotypes of fibroblast-like synoviocytes in rheumatoid arthritis. Int J Biol Macromol 2025;294:139390.

37. Zhang J, Zhang L, Yao G, Zhao H, Qiao P, Wu S. lncRNA-Gm5532 regulates osteoclast differentiation through the miR-125a-3p/TRAF6 axis. Acta Biochim Biophys Sin (Shanghai) 2024;56:54–61.

38. Zhang H, Chen L, Wang Z, et al. Long noncoding RNA KCNQ1OT1 inhibits osteoclast differentiation by regulating the miR-128-3p/NFAT5 axis. Aging (Albany NY) 2022;14:4486–4499.

39. Kay J, Upchurch KS. ACR/EULAR 2010 rheumatoid arthritis classification criteria. Rheumatology (Oxford). 2012;51:Suppl 6. vi5–vi9.

40. Xia J, Gao H, Tang J, et al. A novel diagnostic model based on lncRNA PTPRE expression, neutrophil count and red blood cell distribution width for diagnosis of seronegative rheumatoid arthritis. Clin Exp Med 2024;24:86.